Background: Acute myocarditis, a primary inflammatory cardiac disease commonly caused by viral infection, is an important cause of morbidity and mortality in children. Data obtained from forensic studies found an incidence of 15-33% for acute myocarditis in sudden deaths in the pediatric age group. Currently, there is a lack of data regarding the incidence and factors associated with short-term outcomes in pediatric patients admitted for acute myocarditis. The aim of the study was to identify predictors for in-hospital mortality in a pediatric population admitted with acute myocarditis. Material and methods: We conducted a retrospective observational cohort study that included 21 patients admitted for acute myocarditis. Clinical, laboratory, ECG, and imaging data acquired via 2D transthoracic echocardiography and cardiac magnetic resonance imaging were collected from the medical charts of each included patient. The primary end-point of the study was all-cause mortality occurring during hospitalization (period ranging from 10 to 14 days). The study population was divided into 2 groups according to the occurrence of the primary end-point. Results: The mean age of the study population was 99.62 ± 77.25 months, and 61.90% (n = 13) of the patients were males. The in-hospital mortality rate was 23.9% (n = 5). Patients in the deceased group were significantly younger than the survivors (55.60 ± 56.18 months vs. 113.4 ± 78.50 months, p = 0.039). Patients that had deceased presented a significantly higher level of LDH (365 ± 21.38 U/L vs. 234.4 ± 63.30 U/L, p = 0.0002) and a significantly higher rate of ventricular extrasystolic dysrhythmias (60% vs. 6.25%, p = 0.02, OR: 22.5, 95% CI: 1.5-335) compared to survivors. The 2D echocardiography showed that patients that had deceased presented more frequently an impaired left ventricular ejection fraction (<30%) (p = 0.001) and a significantly higher rate of severe mitral regurgitation (p = 0.001) compared to survivors. Conclusions: The most powerful predictors for in-hospital mortality in pediatric patients admitted for acute myocarditis were the presence of ventricular extrasystolic dysrhythmias on the 24h Holter ECG monitoring, impaired left ventricular systolic function (LVEF <30%), the presence of severe mitral regurgitation, and confirmed infection with Mycoplasma pneumoniae.
INTRODuCTION
Acute myocarditis is a primary inflammatory cardiac disease with a favorable prognosis, the full recovery rate being around 80%. The most frequent etiology of acute myocarditis in children is a viral infection (adenoviruses, enteroviruses). The real prevalence of myocarditis in the pediatric population is still unknown. [1] [2] [3] And even though the incidence of pediatric myocarditis is also unknown, current published data confirm the high mortality rates amongst infants and young children, ranging from 25% to 75%. Data obtained from forensic studies found an incidence of 15-33% for acute myocarditis in sudden deaths in the pediatric age group. [4] [5] [6] Despite its rarity, the illness is an important cause of morbidity and mortality in children. 7, 8 Myocarditis can lead to heart failure, dilated cardiomyopathy, or death. The disease frequently has an insidious onset, and often patients present a recent history of a viral infection.
The initial diagnosis is based on the clinical presentation, which may vary from a lack of symptoms to signs of cardiogenic shock. 1, [9] [10] [11] [12] Cardiovascular signs are minimal, but certain signs of heart failure, tachycardia, hypotension, syncope (full atrioventricular block or other tachyarrhythmia), chest pain, or even cardiogenic shock can also be found. 2, 8, [11] [12] [13] [14] [15] The management and diagnosis of patients with acute myocarditis remains a challenge. 4, 5, [9] [10] [11] [12] 23 Currently, there is a lack of data regarding the incidence and factors associated with short-term outcomes in pediatric patients admitted for acute myocarditis.
The aim of this study was to identify clinical and paraclinical (laboratory, ECG, imaging) predictors for in-hospital mortality in a pediatric population admitted for acute myocarditis.
MATERIAL AND METHODS
The study included 21 patients admitted with acute myo- The primary end-point of the study was all-cause mortality occurring during hospitalization (which ranged from 10 to 14 days). The study population was divided into two groups according to the occurrence of the primary end-point.
StatiStical analySiS
The data obtained was entered into a Microsoft Office Excel database and subsequently processed using the GraphPad Prism 7 software (GraphPad Software San Diego, CA, USA). Quantitative data were tested for normality of distribution using the D'Agostino Pearson Omnibus test and were subsequently compared with Student's t test or the Mann-Whitney test when appropriate.
Nominal data were analyzed using the Chi square test or its alternates when appropriate and were expressed as numbers and percentages. Multivariate analysis was per-formed to identify predictive factors associated with inhospital mortality in pediatric patients with acute myocarditis. All the performed tests were two-tailed, and the statistical significance of the study was set at an alpha coefficient of 0.05.
RESuLTS
The baseline clinical, laboratory, ECG, and imaging characteristics of the 21 study patients are presented in Table 1. The mean age of the study population was 99.62 ± 77.25 months (ranging from 1 month to 204 months), and 61.90% (n = 13) of the patients were males. The in-hospital mortality rate was 23.9% (n = 5, out of which 40% males; n = 2). From the total number of deceased patients, 2 were infants (average age 3.83 months). The analysis of clinical presentation and medical history revealed that the most common symptom at presentation was decreased effort capacity (80.95%, n = 17) followed by respira- Comorbidities were present in 52.4% of the cases (n = 11), including recurrent bronchiolitis in 2 children (9.5%), or immunoglobulin A deficit in 2 children (9.5%).
Also, one child was obese, one child had chronic adenoiditis, and one child had allergic rhinitis.
Patients in the deceased group were significantly younger than the survivors (55.60 ± 56.18 months vs.
113.4 ± 78.50 months, p = 0.039). There was no statistically significant difference between the deceased and survivors regarding gender (p = 0.325), the presence of digestive (p = 1.000) or respiratory symptoms (p = 0.310), sensory deficit (p = 0.428), poor weight gain (p = 0.428), or decreased effort capacity (p = 1.000). However, patients in the deceased group presented a significantly higher rate of hepatomegaly compared to survivors (100% vs. 18.75%, p = 0.002), while chest pain as an initial presentation symptom was more frequently present in the survivor group (0% vs. 62.5%, p = 0.03).
Laboratory tests revealed no significant differences between the two groups regarding the complete blood count, troponin levels (p = 0.123), erythrocyte sedimentation rate (p = 0.338), positive C-reactive protein (qualitative assessment) (p = 0.635), or liver enzymes (ASAT: p = 0.887;
ALAT: p = 0.450). However, patients that had deceased presented a significantly higher level of LDH (365 ± 21.38 U/L vs. 234.4 ± 63.30 U/L, p = 0.0002).
There were no statistically significant differences between the deceased and survivors regarding electrocardiographic changes on the surface ECG; however, the 24h
Holter monitoring showed that there was a significantly higher rate of ventricular extrasystolic dysrhythmias in patients that had deceased compared to survivors (Figure 2 ).
The transthoracic 2D echocardiography showed that patients who had deceased presented more frequently an impaired left ventricular ejection fraction (<30%) (p = 0.001) and a significantly higher rate of severe mitral regurgitation (p = 0.001) compared to survivors (Figure 3) .
The viral infection confirmed via serology did not influence the study end-point in the analyzed population, with the exception of a Mycoplasma pneumoniae infection, which was present in 2 cases (9.52%), both in the deceased group ( (Table 3) .
DISCuSSIONS
In this retrospective study, we aimed to identify factors associated with in-hospital mortality in pediatric patients admitted with acute myocarditis. We analyzed the clinical primary pericarditis syndrome, with minor myocardial involvement. 26 Despite being the gold-standard diagnostic method, EMB was only performed in 3 cases (14.28%). Generally, EMB is considered safe in adult populations with suspected myocarditis. However, it is rarely performed in the pediatric age group, both due to the lack of available facilities and experience, as well as because of the associated risk for myocardial injury and intraprocedural complications. 27, 28 The etiology of myocarditis can be infectious, autoimmune, and toxic, with a predominance of a viral origin. Routine echocardiographic diagnostic criteria include left ventricle dilation (Dubois formula), ejection fraction <30%, significant mitral regurgitation, as well as the dp/ dt parameter with a value below 800 mmHg. [19] [20] [21] [22] 40 Despite being the most useful imaging technique for identifying structural and functional changes, there are no specific echocardiographic criteria for the diagnosis of myocarditis, and these changes are generally not enough to differentiate from other forms of cardiomyopathies. In agreement with previous studies, we also found that a decreased left ventricular ejection fraction is associated with worse in-hospital outcomes, which again established the role of bedside echocardiography in providing diagnostic, therapeutic, and prognostic information in this subset of patients. 24 MRI is a promising diagnostic method for myocarditis.
Imaging investigations were completed by a cardiac MRI
with contrast in 10 cases, which described a positive criterion (Lake Louise) for myocarditis in 8 cases. [19] [20] [21] 25, 41 The present study has depicted a series of clinical and paraclinical factors that can predict worse in-hospital outcomes of pediatric patients that are admitted for acute myocarditis. The presence of ventricular dysrhythmia on the 24h Holter monitoring, the impaired left ventricular ejection fraction, and the confirmed infection with Mycoplasma pneumoniae were found to be the most significantly associated with the occurrence of in-hospital death. The main limitations of the present study are its retrospective nature and the relatively low number of patients. Future prospective studies on the matter are required in order to define a more precise predictive tool for both short-and long-term outcomes of patients with acute myocarditis within the pediatric age group.
